Transcriptomics

Dataset Information

0

Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells


ABSTRACT: Inevitable gefitinib resistance and relapse of the disease was the biggest hurdle to NSCLC treatment. Importantly, the role of hypoxia in solid tumor tissues in vivo in gefitinib acquired resistance and its relationship to lung cancer stem cells (LCSCs) has not been fully elucidated. Here, the PC9 cells were treated with short term gefitinib or/and hypoxia, also, PC9 gefitnib resistant (PC9-GR) cell line was established and ALDH positive PC9 cells were sorted by FACs. Transcriptome analysis among those PC9 cell groups revealed the important role of hypoxia in gefitinib acquired resistance and signaling transduction change, which may critical for NSCLC disease progression and recurrence.

ORGANISM(S): Homo sapiens

PROVIDER: GSE69599 | GEO | 2017/10/31

SECONDARY ACCESSION(S): PRJNA285956

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2016-07-01 | E-GEOD-75308 | biostudies-arrayexpress
2022-04-11 | GSE169513 | GEO
2014-01-01 | E-GEOD-34228 | biostudies-arrayexpress
2016-07-01 | GSE75308 | GEO
2018-02-21 | GSE110815 | GEO
2019-12-31 | GSE123066 | GEO
2014-01-01 | GSE34228 | GEO
2020-12-19 | E-MTAB-9452 | biostudies-arrayexpress
2021-07-01 | GSE117846 | GEO
2019-05-15 | GSE129221 | GEO